Catot, Mark C.
HRN: 21-87-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2022
AMPICILLIN 250MG (VIAL)
09/01/2022
09/08/2022
IV
150mg
Q6
AGE With Mod Dehydration
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes